30 May 2024
Hogan Lovells represents Optinose in its US$55 million registered direct offering
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Steve Abrams Lead | Hogan Lovells Cadwalader | Partner | Not stated | Philadelphia |
| Stephen Nicolai Lead | Hogan Lovells Cadwalader | Partner | Not stated | Philadelphia |
| Amanda Brown | Hogan Lovells Cadwalader | Senior associate | Not stated | Philadelphia |
| Pablo Castiella | Hogan Lovells Cadwalader | Trainee | Not stated | Philadelphia |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 55m (US$55 million)
- What the figure measures
- Issue size
- Client
- Optinose, Inc.Issuer
- Counterparties
- existing and new institutional investors (Investor)